中文 | English
Return
Total: 4 , 1/1
Show Home Prev Next End page: GO
Author:(Zhengbo LIAO)

1.Study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer

Zhiwei CHEN ; Zhengbo SONG ; Yongfeng YU ; Ziming LI ; Shun LU ; Meilin LIAO

Cancer Research and Clinic 2010;22(1):32-34

2.Enrichment of Wee1/CDC2 and NF-κB Signaling Pathway Constituents Mutually Contributes to CDDP Resistance in Human Osteosarcoma

Zhengbo HU ; Lugen LI ; Wenxing LAN ; Xiao WEI ; Xiangyuan WEN ; Penghuan WU ; Xianliao ZHANG ; Xinhua XI ; Yufa LI ; Liqi WU ; Wenhu LI ; Xiaohong LIAO

Cancer Research and Treatment 2022;54(1):277-293

3.Effects of JEV infection on TLRs signaling pathway and its regulation on secretion of inflammatory factors in Leydig cells

Song HE ; Rentan YAN ; Deyuan TANG ; Zhiyong ZENG ; Bin WANG ; Yinming MAO ; Piao ZHOU ; Zhengbo LIAO ; Xu CHEN ; Shenglin YUAN ; Wenwen HU ; Min ZHOU

Chinese Journal of Veterinary Science 2024;44(11):2409-2417

4.Research progress of immune response mechanisms and prevention and control of porcine circovirus type 2

Yinming MAO ; Deyuan TANG ; Zhiyong ZENG ; Bin WANG ; Tao HUANG ; Song HE ; Piao ZHOU ; Zhengbo LIAO ; Shenglin YUAN ; Xu CHEN

Chinese Journal of Veterinary Science 2024;44(11):2483-2489

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4 , 1/1 Show Home Prev Next End page: GO